JP2023145499A5 - - Google Patents

Download PDF

Info

Publication number
JP2023145499A5
JP2023145499A5 JP2023112878A JP2023112878A JP2023145499A5 JP 2023145499 A5 JP2023145499 A5 JP 2023145499A5 JP 2023112878 A JP2023112878 A JP 2023112878A JP 2023112878 A JP2023112878 A JP 2023112878A JP 2023145499 A5 JP2023145499 A5 JP 2023145499A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
promoter
acid position
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023112878A
Other languages
English (en)
Japanese (ja)
Other versions
JP7554320B2 (ja
JP2023145499A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/065519 external-priority patent/WO2019118760A1/en
Application filed filed Critical
Publication of JP2023145499A publication Critical patent/JP2023145499A/ja
Publication of JP2023145499A5 publication Critical patent/JP2023145499A5/ja
Priority to JP2024153716A priority Critical patent/JP2024178213A/ja
Application granted granted Critical
Publication of JP7554320B2 publication Critical patent/JP7554320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023112878A 2017-12-13 2023-07-10 メソセリンを標的とするがんワクチンおよびその使用 Active JP7554320B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024153716A JP2024178213A (ja) 2017-12-13 2024-09-06 メソセリンを標的とするがんワクチンおよびその使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762598289P 2017-12-13 2017-12-13
US62/598,289 2017-12-13
PCT/US2018/065519 WO2019118760A1 (en) 2017-12-13 2018-12-13 Cancer vaccines targeting mesothelin and uses thereof
JP2020532723A JP7352547B2 (ja) 2017-12-13 2018-12-13 メソセリンを標的とするがんワクチンおよびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020532723A Division JP7352547B2 (ja) 2017-12-13 2018-12-13 メソセリンを標的とするがんワクチンおよびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024153716A Division JP2024178213A (ja) 2017-12-13 2024-09-06 メソセリンを標的とするがんワクチンおよびその使用

Publications (3)

Publication Number Publication Date
JP2023145499A JP2023145499A (ja) 2023-10-11
JP2023145499A5 true JP2023145499A5 (https=) 2023-11-07
JP7554320B2 JP7554320B2 (ja) 2024-09-19

Family

ID=66734859

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020532723A Active JP7352547B2 (ja) 2017-12-13 2018-12-13 メソセリンを標的とするがんワクチンおよびその使用
JP2023112878A Active JP7554320B2 (ja) 2017-12-13 2023-07-10 メソセリンを標的とするがんワクチンおよびその使用
JP2024153716A Withdrawn JP2024178213A (ja) 2017-12-13 2024-09-06 メソセリンを標的とするがんワクチンおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020532723A Active JP7352547B2 (ja) 2017-12-13 2018-12-13 メソセリンを標的とするがんワクチンおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024153716A Withdrawn JP2024178213A (ja) 2017-12-13 2024-09-06 メソセリンを標的とするがんワクチンおよびその使用

Country Status (11)

Country Link
US (3) US11154602B2 (https=)
EP (1) EP3723810A4 (https=)
JP (3) JP7352547B2 (https=)
KR (2) KR20240024366A (https=)
CN (1) CN111479590A (https=)
AU (2) AU2018383658B2 (https=)
BR (1) BR112020010499A2 (https=)
CA (1) CA3083528C (https=)
MX (1) MX2020006226A (https=)
RU (1) RU2751252C1 (https=)
WO (1) WO2019118760A1 (https=)

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US54533A (en) 1866-05-08 Improvement in invalid-bedsteads
US21579A (en) 1858-09-21 Rotary valve fob steam-engines
US5077044A (en) 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5338683A (en) 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US5110587A (en) 1981-12-24 1992-05-05 Health Research, Incorporated Immunogenic composition comprising synthetically modified vaccinia virus
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
ZA858044B (en) 1984-11-01 1987-05-27 American Home Prod Oral vaccines
US5643579A (en) 1984-11-01 1997-07-01 American Home Products Corporation Oral vaccines
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
GB8508845D0 (en) 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
US5223424A (en) 1985-09-06 1993-06-29 Prutech Research And Development Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
US4790987A (en) 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
US5310668A (en) 1986-06-20 1994-05-10 Merck & Co., Inc. Varicella-zoster virus as a live recombinant vaccine
US5242829A (en) 1986-09-23 1993-09-07 Therion Biologics Corporation Recombinant pseudorabies virus
US5387744A (en) 1987-06-04 1995-02-07 Washington University Avirulent microbes and uses therefor: Salmonella typhi
IL86583A0 (en) 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5294441A (en) 1987-06-04 1994-03-15 Washington University Avirulent microbes and uses therefor: salmonella typhi
US5112749A (en) 1987-10-02 1992-05-12 Praxis Biologics, Inc. Vaccines for the malaria circumsporozoite protein
US5225336A (en) 1989-03-08 1993-07-06 Health Research Incorporated Recombinant poxvirus host range selection system
JP3044062B2 (ja) 1989-03-08 2000-05-22 ヘルス・リサーチ・インク 組換えポックスウイルス宿主選択系
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5591439A (en) 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
EP0465560B1 (en) 1989-03-31 1996-06-05 Washington University VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS
EP0431668B1 (en) 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
US5294548A (en) 1990-04-02 1994-03-15 American Biogenetic Sciences, Inc Recombianant Hepatitis a virus
WO1991018088A1 (en) 1990-05-23 1991-11-28 The United States Of America, Represented By The Secretary, United States Department Of Commerce Adeno-associated virus (aav)-based eucaryotic vectors
US5462734A (en) 1990-11-02 1995-10-31 Wisconsin Alumni Research Foundation Bovine herpesvirus vaccine and method of using same
US5240703A (en) 1991-03-01 1993-08-31 Syntro Corporation Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
US6034298A (en) 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5955088A (en) 1992-02-03 1999-09-21 Cedars-Sinai Medical Center Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
EP0646178A1 (en) 1992-06-04 1995-04-05 The Regents Of The University Of California expression cassette with regularoty regions functional in the mammmlian host
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
AU675702B2 (en) 1993-01-26 1997-02-13 Leslie R. Coney Compositions and methods for delivery of genetic material
US5981505A (en) 1993-01-26 1999-11-09 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
EP0708659A4 (en) 1993-06-07 2000-08-23 Genentech Inc HIV ENVELOPE POLYPEPTIDES
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US6156319A (en) 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
NL9401820A (nl) 1994-11-02 1996-06-03 Meyn Maschf Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
US5962428A (en) 1995-03-30 1999-10-05 Apollon, Inc. Compositions and methods for delivery of genetic material
US5650309A (en) 1995-05-16 1997-07-22 The Regents Of The University Of California Viral vectors
US5698202A (en) 1995-06-05 1997-12-16 The Wistar Institute Of Anatomy & Biology Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
KR100780158B1 (ko) 1996-10-23 2007-11-27 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 면역 치료법 및 개량 백신
JP2001520537A (ja) 1997-04-03 2001-10-30 エレクトロフェクト・アクティーゼルスカブ 医薬品と核酸の骨格筋への導入方法
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
HUP0004589A3 (en) 1997-06-30 2003-08-28 Centre Nat Rech Scient Improved method for transferring nucleic acid into the striped muscle and combination therefor
IL138075A0 (en) 1998-02-27 2001-10-31 Univ Pennsylvania Vaccines, immunotherapeutics and methods for using the same
EP1100579B1 (en) 1998-07-13 2015-09-02 Inovio Pharmaceuticals, Inc. Skin and muscle-targeted gene therapy by pulsed electrical field
US6589529B1 (en) 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
CA2633171C (en) 2001-06-20 2012-11-20 Genentech, Inc. Antibodies against tumor-associated antigenic target (tat) polypeptides
JP3543326B2 (ja) 2001-08-30 2004-07-14 ソニー株式会社 情報処理装置および方法、情報処理システム、情報配信装置、記録媒体、並びにプログラム
US8209006B2 (en) 2002-03-07 2012-06-26 Vgx Pharmaceuticals, Inc. Constant current electroporation device and methods of use
US7245963B2 (en) 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
US7328064B2 (en) 2002-07-04 2008-02-05 Inovio As Electroporation device and injection apparatus
US9200036B2 (en) 2002-07-12 2015-12-01 The Johns Hopkins University Mesothelin vaccines and model systems
CA2504593C (en) 2002-11-04 2016-08-09 Advisys, Inc. Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
EP1628749B1 (en) 2003-05-30 2019-07-31 VGXI, Inc. Devices and methods for biomaterial production
US8008265B2 (en) 2003-06-13 2011-08-30 The Trustees Of The University Of Pennsylvania Vaccines, immunotherapeutics and methods for using the same
NZ570709A (en) 2003-06-13 2010-04-30 Univ Pennsylvania Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
WO2007050095A2 (en) 2004-11-19 2007-05-03 The Trustees Of The University Of Pennsylvania Improved vaccines and methods for using the same
KR101421745B1 (ko) 2006-01-13 2014-07-22 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 코돈 최적화된 il―15를 사용하는 백신 및 면역치료제, 및 그의 사용 방법
WO2007103225A2 (en) 2006-03-01 2007-09-13 Anza Therapeutics, Inc. Engineered listeria and methods of use thereof
WO2007117371A2 (en) * 2006-03-01 2007-10-18 Anza Therapeutics, Inc. Engineered listeria and methods of use thereof
US7935804B2 (en) * 2006-03-01 2011-05-03 Aduro Biotech Engineered Listeria and methods of use thereof
ES2993941T3 (en) 2006-10-17 2025-01-14 Inovio Pharmaceuticals Inc Electroporation devices for electroporation of cells in mammals
EP2153260B1 (en) 2007-05-23 2017-01-25 VGXI, Inc. Composition comprising high concentration of biologically active molecules and processes for preparing the same
US10071154B2 (en) 2008-04-04 2018-09-11 The Trustees Of The University Of Pennsylvania Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
CN102821790A (zh) 2009-09-14 2012-12-12 宾夕法尼亚大学托管会 包含IL-15受体α和/或编码IL-15受体α的核酸分子的疫苗和免疫治疗剂,以及其使用方法
CA2788902C (en) 2010-02-08 2019-09-03 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
ES2613630T3 (es) 2010-05-23 2017-05-25 Aduro Biotech, Inc. Métodos y composiciones que utilizan Listeria para un tratamiento auxiliar del cáncer
EP2603581B1 (en) 2010-08-11 2019-07-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Cocultures of cumulus cells and embryos during in vitro fertilization procedures
RU2600067C2 (ru) 2011-05-06 2016-10-20 Дзе Гавермент Оф Дзе Юнайтед Стейтс Оф Америка Эз Репрезентед Бай Дзе Секретари Оф Дзе Депармент Оф Хелс Энд Хьюман Сёрвисез Рекомбинантный иммунотоксин, нацеленный на мезотелин
AU2013243948A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
SG10201609210SA (en) * 2012-05-03 2016-12-29 Hutchinson Fred Cancer Res Enhanced affinity t cell receptors and methods for making the same
GB2504774A (en) 2012-08-10 2014-02-12 Munster Simms Eng Ltd Diaphragm pump with integral motor housing and rear pump housing
CN104955845B (zh) * 2012-09-27 2018-11-16 美国政府(由卫生和人类服务部的部长所代表) 间皮素抗体和引起有效的抗肿瘤活性的方法
AU2014228405B2 (en) 2013-03-15 2017-05-11 The Trustees Of The University Of Pennsylvania Cancer vaccines and methods of treatment using the same
PL3082850T3 (pl) 2013-12-18 2020-01-31 Vaximm Gmbh Celowana szczepionka DNA MSLN w immunoterapii nowotworu
TWI548337B (zh) 2015-10-16 2016-09-01 技嘉科技股份有限公司 散熱模組、顯示卡組件及電子裝置

Similar Documents

Publication Publication Date Title
EP3319633B1 (en) Vaccine against rsv
JP2022160401A5 (https=)
US20210093707A1 (en) Zika virus purification
Kinney et al. Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins
JP2020515640A5 (https=)
CN115246874B (zh) 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用
CN111533812B (zh) 针对sars-cov-2病毒的dna疫苗及其用途
EP2185584A1 (en) Interferon fusion proteins
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
JPWO2018234492A5 (https=)
WO2020072371A1 (en) Melanoma canine vaccine compositions and methods of use thereof
JP2024023358A5 (https=)
JP2023145499A5 (https=)
JP2005512518A5 (https=)
Yang et al. Cloning and characterization of a novel feline IFN-ω
CZ20011521A3 (cs) Farmaceutický prostředek obsahující fragmenty DNA kódující antigenní protein vykazující protinádorový účinek
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
JP2023155245A5 (https=)
WO2021233094A1 (zh) 干扰素-κ突变体及其制备方法
JP2023111915A5 (https=)
JP2002510496A (ja) 細胞傷害性t細胞を誘導するための医薬
KR102889144B1 (ko) 박테리오파지 vlp를 포함하는 어주번트 조성물
JPWO2021198701A5 (https=)
JP3565579B2 (ja) ネコ伝染性腹膜炎i型ウイルスのスパイク蛋白質遺伝子rnaに対応するdna
JPWO2023057766A5 (https=)